Belzutifan is a pharmaceutical raw material that acts as an inhibitor of hypoxia-inducible factor 2α (HIF-2α). It is used in research and manufacturing related to certain cancer pathways, particularly those associated with von Hippel-Lindau disease.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1672668-24-4
Tropine benzylate hydrochloride
pharmaceutical raw material
Ornidazole
pharmaceutical raw material
Desmopressin diacetate
pharmaceutical raw material
Flibanserin
pharmaceutical raw material
HIF-2alpha-IN-2
research compound
3-[[(1S)-7-(difluoromethylsulfonyl)-2,2-difluoro-1-hydroxy-1,3-dihydroinden-4-yl]oxy]-5-fluorobenzonitrile
research compound
3-[[(1S,2S,3R)-2,3-difluoro-1-hydroxy-7-methylsulfonyl-2,3-dihydro-1H-inden-4-yl]oxy]-5-fluorobenzonitrile
LOMMPXLFBTZENJ-ZACQAIPSSA-N
CS(=O)(=O)C1=C2[C@@H]([C@@H]([C@@H](C2=C(C=C1)OC3=CC(=CC(=C3)C#N)F)F)F)O